EDGAR Filing Documents for 0000950133-06-005154

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0000950133-06-005154

Filing Date

2006-11-29

Accepted

2006-11-29 09:02:06

Documents

Period of Report

2006-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 20-F	w27560e20vf.htm	20-F	1190564
2	EXHIBIT 4.1	w27560exv4w1.htm	EX-4.1	117574
3	EXHIBIT 4.2	w27560exv4w2.htm	EX-4.2	118459
4	EXHIBIT 4.3	w27560exv4w3.htm	EX-4.3	113886
5	EXHIBIT 4.5	w27560exv4w5.htm	EX-4.5	107585
6	EXHIBIT 4.6	w27560exv4w6.htm	EX-4.6	107631
7	EXHIBIT 4.7	w27560exv4w7.htm	EX-4.7	112325
8	EXHIBIT 4.8	w27560exv4w8.htm	EX-4.8	118652
9	EXHIBIT 8.1	w27560exv8w1.htm	EX-8.1	8026
10	EXHIBIT 12.1	w27560exv12w1.htm	EX-12.1	7863
11	EXHIBIT 12.2	w27560exv12w2.htm	EX-12.2	7253
12	EXHIBIT 13.1	w27560exv13w1.htm	EX-13.1	4453
	Complete submission text file	0000950133-06-005154.txt		2015644

Mailing Address 107 NORTH RYDE SYDNEY C3 1670

Business Address 140 WICKS RD NORTH RYDE NEW SOUTH WALES 2113 C3 2113 01161298780088

NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-29962 | Film No.: 061243647
SIC: 2834 Pharmaceutical Preparations